DekaBank Deutsche Girozentrale - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 105 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q4 2015$88,000
-8.3%
31,000
+1.6%
0.00%0.0%
Q3 2015$96,000
-22.6%
30,500
+45.2%
0.00%0.0%
Q2 2015$124,000
-35.4%
21,000
+16.7%
0.00%
-50.0%
Q1 2015$192,00018,0000.00%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q3 2015
NameSharesValueWeighting ↓
Sageview Capital 2,223,339$5,603,0001.59%
Orbimed Advisors 2,320,800$5,848,0000.09%
F&C Asset Management plc 1,854,808$4,665,0000.06%
SPHERA FUNDS MANAGEMENT LTD. 56,500$142,0000.04%
Yakira Capital Management, Inc. 11,957$30,0000.03%
Spectrum Management Group, LLC 10,000$25,0000.02%
Weiss Multi-Strategy Advisers LLC 41,152$104,0000.00%
WOLVERINE ASSET MANAGEMENT LLC 30,000$75,0000.00%
PUTNAM INVESTMENTS LLC 129,762$327,0000.00%
Partnervest Advisory Services LLC 220$1,0000.00%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders